Hurtado-Carneiro V, Sanz C, Roncero I, Vazquez P, Blazquez E, Alvarez E
Clinical trials show that meaningful percentage weight loss often develops over several months, especially when medication is paired with diet and activity changes
Never mix insulin and GLP-1 agonists in the same syringe unless specifically using a combination product designed for this purpose
Kidney Disease and Acute Kidney Injury Reports have also linked GLP-1 receptor agonist drugs to kidney disease and acute kidney injury, sometimes requiring dialysis or long-term treatment
It emphasizes daily protein targets, fruits and vegetables, hydration and physical activity," explained Cardel